XTANT MEDICAL HOLDINGS, INC. Selling and Marketing Expense
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Selling and Marketing Expense of $10.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for the quarter ending 2026-06-30 was $10.37M, a 10.74% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for the quarter ending 2026-03-31 was $8.19M, a 26.94% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for the quarter ending 2025-12-31 was $10.95M, a 6.32% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for the quarter ending 2025-09-30 was $11.75M, a 1.21% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for fiscal 2025 was $45.51M, a 7.52% decline from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for fiscal 2024 was $49.21M, a 28.03% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for fiscal 2023 was $38.44M, a 70.73% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. selling and marketing expense for fiscal 2022 was $22.52M, a 7.09% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.37M 10-Q · filed 2026-08-11 | $18.55M 10-Q · filed 2026-08-11 | $29.50M derived: sum of 3 quarters · filed 2026-08-11 | $41.25M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $8.19M 10-Q · filed 2026-05-13 | $19.13M derived: sum of 2 quarters · filed 2026-05-13 | $30.88M derived: sum of 3 quarters · filed 2026-05-13 | $42.49M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $22.69M derived: sum of 2 quarters · filed 2026-03-31 | $34.31M derived: sum of 3 quarters · filed 2026-08-11 | $45.51M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $11.75M 10-Q · filed 2025-11-10 | $23.36M derived: sum of 2 quarters · filed 2026-08-11 | $34.57M 10-Q · filed 2025-11-10 | $46.25M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $11.62M 10-Q · filed 2026-08-11 | $22.82M 10-Q · filed 2026-08-11 | $34.50M derived: sum of 3 quarters · filed 2026-08-11 | $46.39M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $11.20M 10-Q · filed 2026-05-13 | $22.89M derived: sum of 2 quarters · filed 2026-05-13 | $34.78M derived: sum of 3 quarters · filed 2026-05-13 | $47.96M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $11.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $23.57M derived: sum of 2 quarters · filed 2026-03-31 | $36.75M derived: sum of 3 quarters · filed 2026-03-31 | $49.21M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $11.89M 10-Q · filed 2025-11-10 | $25.07M derived: sum of 2 quarters · filed 2025-11-10 | $37.53M 10-Q · filed 2025-11-10 | $49.11M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $13.18M 10-Q · filed 2025-08-12 | $25.64M 10-Q · filed 2025-08-12 | $37.22M derived: sum of 3 quarters · filed 2025-08-12 | $48.31M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $12.46M 10-Q · filed 2025-05-12 | $24.04M derived: sum of 2 quarters · filed 2025-05-12 | $35.13M derived: sum of 3 quarters · filed 2025-05-12 | $43.84M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $22.67M derived: sum of 2 quarters · filed 2025-03-06 | $31.39M derived: sum of 3 quarters · filed 2025-03-06 | $38.44M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $11.09M 10-Q · filed 2024-11-12 | $19.80M derived: sum of 2 quarters · filed 2024-11-12 | $26.86M 10-Q · filed 2024-11-12 | $32.69M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $8.72M 10-Q · filed 2024-08-08 | $15.77M 10-Q · filed 2024-08-08 | $21.60M derived: sum of 3 quarters · filed 2024-08-08 | $27.44M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $7.05M 10-Q · filed 2024-05-15 | $12.89M derived: sum of 2 quarters · filed 2024-05-15 | $18.72M derived: sum of 3 quarters · filed 2024-05-15 | $24.36M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $11.67M derived: sum of 2 quarters · filed 2024-04-01 | $17.31M derived: sum of 3 quarters · filed 2024-04-01 | $22.52M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $5.84M 10-Q · filed 2023-11-14 | $11.47M derived: sum of 2 quarters · filed 2023-11-14 | $16.68M 10-Q · filed 2023-11-14 | $22.00M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $5.64M 10-Q · filed 2023-08-01 | $10.85M 10-Q · filed 2023-08-01 | $16.16M derived: sum of 3 quarters · filed 2023-08-01 | $21.43M derived: sum of 4 quarters · filed 2023-08-01 | ||||
| 2022-03-31 | $5.21M 10-Q · filed 2023-05-04 | $10.52M derived: sum of 2 quarters · filed 2023-05-04 | $15.79M derived: sum of 3 quarters · filed 2023-05-04 | $21.38M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $10.58M derived: sum of 2 quarters · filed 2023-03-07 | $16.17M derived: sum of 3 quarters · filed 2023-03-07 | $21.02M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $5.27M 10-Q · filed 2022-11-03 | $10.86M derived: sum of 2 quarters · filed 2022-11-03 | $15.71M 10-Q · filed 2022-11-03 | $21.12M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $5.59M 10-Q · filed 2022-08-04 | $10.45M 10-Q · filed 2022-08-04 | $15.85M derived: sum of 3 quarters · filed 2022-08-04 | $21.12M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $4.86M 10-Q · filed 2022-05-05 | $10.26M derived: sum of 2 quarters · filed 2022-05-05 | $15.53M derived: sum of 3 quarters · filed 2022-05-05 | $19.43M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $10.68M derived: sum of 2 quarters · filed 2022-03-08 | $14.57M derived: sum of 3 quarters · filed 2022-03-08 | $20.98M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $5.27M 10-Q · filed 2021-11-12 | $9.16M derived: sum of 2 quarters · filed 2021-11-12 | $15.58M 10-Q · filed 2021-11-12 | $22.57M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $3.90M 10-Q · filed 2021-08-05 | $10.31M 10-Q · filed 2021-08-05 | $17.30M derived: sum of 3 quarters · filed 2021-08-05 | $23.99M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $6.41M 10-Q · filed 2021-05-11 | $13.41M derived: sum of 2 quarters · filed 2021-05-11 | $20.09M derived: sum of 3 quarters · filed 2021-05-11 | $26.16M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $13.68M derived: sum of 2 quarters · filed 2021-02-24 | $19.75M derived: sum of 3 quarters · filed 2021-02-24 | $26.49M 10-K · filed 2021-02-24 | $25.84M 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $6.68M 10-Q · filed 2020-10-29 | $6.68M 10-Q · filed 2019-11-07 | $12.76M derived: sum of 2 quarters · filed 2020-10-29 | $19.50M 10-Q · filed 2020-10-29 | $19.50M 10-Q · filed 2019-11-07 | $26.22M derived: sum of 4 quarters · filed 2020-10-29 | ||
| 2019-06-30 | $6.07M 10-Q · filed 2020-08-03 | $12.81M 10-Q · filed 2020-08-03 | $19.54M derived: sum of 3 quarters · filed 2020-08-03 | $27.38M derived: sum of 4 quarters · filed 2020-08-03 | ||||
| 2019-03-31 | $6.74M 10-Q · filed 2020-05-07 | $13.46M derived: sum of 2 quarters · filed 2020-05-07 | $21.31M derived: sum of 3 quarters · filed 2020-05-07 | $29.86M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $14.57M derived: sum of 2 quarters · filed 2020-03-05 | $23.11M derived: sum of 3 quarters · filed 2020-03-05 | $31.46M 10-K · filed 2020-03-05 | $32.06M 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $7.85M 10-Q · filed 2019-11-07 | $16.39M derived: sum of 2 quarters · filed 2019-11-07 | $24.74M 10-Q · filed 2019-11-07 | $34.21M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $8.54M 10-Q · filed 2019-08-08 | $16.89M 10-Q · filed 2019-08-08 | $26.37M derived: sum of 3 quarters · filed 2019-08-08 | $35.27M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $8.35M 10-Q · filed 2019-05-15 | $17.82M derived: sum of 2 quarters · filed 2019-05-15 | $26.73M derived: sum of 3 quarters · filed 2019-05-15 | $37.86M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $18.38M derived: sum of 2 quarters · filed 2019-04-01 | $29.51M derived: sum of 3 quarters · filed 2019-04-01 | $40.51M 10-K · filed 2019-04-01 | $40.51M 10-K · filed 2018-04-05 | |||
| 2017-09-30 | $8.90M 10-Q · filed 2018-11-14 | $8.90M 10-Q · filed 2017-11-21 | $20.04M derived: sum of 2 quarters · filed 2018-11-14 | $31.04M 10-Q · filed 2018-11-14 | $31.04M 10-Q · filed 2017-11-21 | $42.98M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $11.14M 10-Q · filed 2018-08-08 | $11.14M 10-Q · filed 2017-08-14 | $22.13M 10-Q · filed 2018-08-08 | $22.13M 10-Q · filed 2017-08-14 | $34.07M derived: sum of 3 quarters · filed 2018-08-08 | $45.32M derived: sum of 4 quarters · filed 2018-08-08 | ||
| 2017-03-31 | $11.00M 10-Q · filed 2018-05-08 | $11.00M 10-Q · filed 2017-05-15 | $22.94M derived: sum of 2 quarters · filed 2018-05-08 | $34.18M derived: sum of 3 quarters · filed 2018-05-08 | $44.60M derived: sum of 4 quarters · filed 2018-05-08 | |||
| 2016-12-31 | $11.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-05 | $23.18M derived: sum of 2 quarters · filed 2018-04-05 | $33.60M derived: sum of 3 quarters · filed 2018-04-05 | $44.06M 10-K · filed 2018-04-05 | ||||
| 2016-09-30 | $11.24M 10-Q · filed 2017-11-21 | $21.66M derived: sum of 2 quarters · filed 2018-03-30 | $32.12M 10-Q · filed 2017-11-21 | $42.73M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-06-30 | $10.42M 10-Q · filed 2018-03-30 | $20.93M 10-Q · filed 2018-03-30 | $31.48M derived: sum of 3 quarters · filed 2018-03-30 | $39.91M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-03-31 | $10.51M 10-Q · filed 2018-03-30 | $21.06M derived: sum of 2 quarters · filed 2018-03-30 | $29.49M derived: sum of 3 quarters · filed 2018-03-30 | $34.53M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2015-12-31 | $10.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $18.98M derived: sum of 2 quarters · filed 2017-03-29 | $24.02M derived: sum of 3 quarters · filed 2017-03-29 | $28.73M 10-K · filed 2017-03-29 | ||||
| 2015-09-30 | $8.43M 10-Q · filed 2016-11-10 | $13.47M derived: sum of 2 quarters · filed 2016-11-10 | $18.18M 10-Q · filed 2016-11-10 | $22.70M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $5.04M 10-Q · filed 2016-08-10 | $9.75M 10-Q · filed 2016-08-10 | $14.27M derived: sum of 3 quarters · filed 2016-08-10 | $18.20M derived: sum of 4 quarters · filed 2016-08-10 | ||||
| 2015-03-31 | $4.71M 10-Q · filed 2016-05-11 | $9.24M derived: sum of 2 quarters · filed 2016-05-11 | $13.17M derived: sum of 3 quarters · filed 2016-05-11 | $17.57M derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $8.45M derived: sum of 2 quarters · filed 2016-03-24 | $12.86M derived: sum of 3 quarters · filed 2016-03-24 | $16.91M 10-K · filed 2016-03-24 | ||||
| 2014-09-30 | $3.93M 10-Q · filed 2015-11-16 | $8.33M derived: sum of 2 quarters · filed 2015-11-16 | $12.39M 10-Q · filed 2015-11-16 | $16.35M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $4.41M 10-Q · filed 2015-08-14 | $8.46M 10-Q · filed 2015-08-14 | $12.42M derived: sum of 3 quarters · filed 2015-08-14 | $16.47M derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | $4.06M 10-Q · filed 2015-05-06 | $8.02M derived: sum of 2 quarters · filed 2015-05-06 | $12.07M derived: sum of 3 quarters · filed 2015-05-06 | $16.27M derived: sum of 4 quarters · filed 2015-05-06 | ||||
| 2013-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $8.01M derived: sum of 2 quarters · filed 2015-03-18 | $12.22M derived: sum of 3 quarters · filed 2015-03-18 | $16.02M 10-K · filed 2015-03-18 | ||||
| 2013-09-30 | $4.05M 10-Q · filed 2014-11-07 | $8.26M derived: sum of 2 quarters · filed 2014-11-07 | $12.06M 10-Q · filed 2014-11-07 | $16.34M derived: sum of 4 quarters · filed 2014-11-07 | ||||
| 2013-06-30 | $4.21M 10-Q · filed 2014-08-14 | $8.00M 10-Q · filed 2014-08-14 | $12.29M derived: sum of 3 quarters · filed 2014-08-14 | $15.64M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $3.80M 10-Q · filed 2014-05-12 | $8.08M derived: sum of 2 quarters · filed 2014-05-12 | $11.43M derived: sum of 3 quarters · filed 2014-05-12 | $15.27M derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $7.64M derived: sum of 2 quarters · filed 2014-03-27 | $11.47M derived: sum of 3 quarters · filed 2014-03-27 | $15.62M 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $3.35M 10-Q · filed 2013-11-14 | $7.19M derived: sum of 2 quarters · filed 2013-11-14 | $11.33M 10-Q · filed 2013-11-14 | $16.43M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $3.84M 10-Q · filed 2013-08-13 | $7.98M 10-Q · filed 2013-08-13 | $13.08M derived: sum of 3 quarters · filed 2013-05-10 | $17.89M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2012-03-31 | $4.15M 10-Q · filed 2013-05-10 | $9.24M derived: sum of 2 quarters · filed 2013-05-10 | $14.05M derived: sum of 3 quarters · filed 2013-05-10 | $18.38M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $9.91M derived: sum of 2 quarters · filed 2013-03-27 | $14.24M derived: sum of 3 quarters · filed 2013-03-27 | $18.50M 10-K · filed 2013-03-27 | ||||
| 2011-09-30 | $4.81M 10-Q · filed 2012-11-08 | $9.14M derived: sum of 2 quarters · filed 2012-11-08 | $13.41M 10-Q · filed 2012-11-08 | $16.84M derived: sum of 4 quarters · filed 2012-11-08 | ||||
| 2011-06-30 | $4.33M 10-Q · filed 2011-08-15 | $8.60M 10-Q · filed 2012-08-10 | $12.03M derived: sum of 3 quarters · filed 2012-08-10 | $14.35M derived: sum of 4 quarters · filed 2012-08-10 | ||||
| 2011-03-31 | $4.26M 10-Q · filed 2012-05-04 | $7.70M derived: sum of 2 quarters · filed 2012-05-04 | $10.02M derived: sum of 3 quarters · filed 2012-05-04 | $11.70M derived: sum of 4 quarters · filed 2012-05-04 | ||||
| 2010-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $5.75M derived: sum of 2 quarters · filed 2012-03-29 | $7.44M derived: sum of 3 quarters · filed 2012-03-29 | $8.90M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $2.32M 10-Q · filed 2011-11-14 | $4.00M derived: sum of 2 quarters · filed 2011-11-14 | $5.47M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $1.68M 10-Q · filed 2011-08-15 | $3.13M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |